Interacting Drugs |
Perphenazine vs Abiraterone Acetate |
Security Level |
|
Mechanism |
Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates. |
Management |
Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible. When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity. |
Perphenazine vs Abiraterone Acetate
Post Review about Perphenazine vs Abiraterone Acetate Click here to cancel reply.
Other Interactions of Perphenazine
Other Interactions of Abiraterone Acetate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.